Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG)
Authors:
- 1 August 1994
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1194 (1) , 185-196
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesinNature, 1991
- Role of CD4 in the Penetration of Cells by HIV1991
- Designing CD4 immunoadhesins for AIDS therapyNature, 1989
- Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaquesNature, 1989
- A soluble CD4 protein selectively inhibits HIV replication and syncytium formationNature, 1988
- Soluble CD4 molecules neutralize human immunodeficiency virus type 1Nature, 1988
- soluble form of CD4 (T4) protein inhibits AIDS virus infectionNature, 1988
- HIV infection is blocked in vitro by recombinant soluble CD4Nature, 1988
- Blocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 AntigenScience, 1987
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984